Načítá se...
Wearing-off at the end of natalizumab dosing intervals is associated with low receptor occupancy
OBJECTIVE: We aimed to investigate whether wearing-off symptoms at the end of the natalizumab dosing interval were associated with clinical and demographic patient characteristics or natalizumab receptor occupancy (RO) on leukocytes. METHODS: In this cross-sectional study of 40 patients with relapsi...
Uloženo v:
| Vydáno v: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Lippincott Williams & Wilkins
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7051203/ https://ncbi.nlm.nih.gov/pubmed/32019768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000678 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|